BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Webster H, Valencia S, Kumar A, Chan C, Dennis M, Roark H, Woods A, John S, Carfi A, Permar SR. Pre-existing immunity to cytomegalovirus in macaques influences human CMV vaccine responses in preclinical models. Vaccine 2021;39:5358-67. [PMID: 34393017 DOI: 10.1016/j.vaccine.2021.08.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang H(, Li L, Nelson CS, Barfield R, Valencia S, Chan C, Muramatsu H, Lin PJ, Pardi N, An Z, Weissman D, Permar SR. Multivalent Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccines Demonstrate a Greater Breadth in T cell but not Antibody Responses.. [DOI: 10.1101/2022.11.23.517695] [Reference Citation Analysis]
2 Strang BL. Toward inhibition of human cytomegalovirus replication with compounds targeting cellular proteins. J Gen Virol 2022;103. [PMID: 36215160 DOI: 10.1099/jgv.0.001795] [Reference Citation Analysis]
3 Qin S, Tang X, Chen Y, Chen K, Fan N, Xiao W, Zheng Q, Li G, Teng Y, Wu M, Song X. mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduct Target Ther 2022;7:166. [PMID: 35597779 DOI: 10.1038/s41392-022-01007-w] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 26.0] [Reference Citation Analysis]
4 Goswami R, Pavon CG, Miller IG, Berendam SJ, Williams CA, Rosenthal D, Gross M, Phan C, Byrd A, Pollara J, Permar SR, Fouda GG. Prenatal Immunization to Prevent Viral Disease Outcomes During Pregnancy and Early Life. Front Virol 2022;2. [DOI: 10.3389/fviro.2022.849995] [Reference Citation Analysis]
5 Zogg H, Singh R, Ro S. Current Advances in RNA Therapeutics for Human Diseases. Int J Mol Sci 2022;23:2736. [PMID: 35269876 DOI: 10.3390/ijms23052736] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]